spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  testosterone gel 

 HSMN NewsFeed - 31 Dec 2015
Acerus Announces Termination of NATESTO(TM) Agreement with Endo
Biopharmaceuticals Distribution
 HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2014
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2014
Auxilium and Sobi Announce Encore Presentation of XIAFLEX/Xiapex Data at European Association of Urology Congress
Biopharmaceuticals Urology
 HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2013
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's Disease Data at SMSNA Scientific Meeting
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Biopharmaceuticals
 HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Oct 2013
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX(R) For The Treatment Of Dupuytren's Contracture
Biopharmaceuticals Othopaedic
 HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jul 2013
BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals
 HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology
 HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Feb 2012
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX(R) in Canada, Australia, Brazil and Mexico
Biopharmaceuticals
 HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 1 Dec 2011
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 7 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Apr 2011
Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by Pfizer
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology
 HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2010
XIAFLEX(R) Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivotal Study
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2010
Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 2 Mar 2010
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol for the Treatment of Overactive Bladder
Biopharmaceuticals Urology Drug Delivery
 HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2010
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jan 2010
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 31 Jul 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jun 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2009
XIAFLEX(TM) for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Apr 2009
BioSante Announces Launch of Elestrin in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2009
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Feb 2009
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Dec 2008
Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc to Acquire U.S. Rights to Elestrin (TM)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Aug 2008
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of Hot Flashes
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Jun 2008
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
BioSante Pharmaceuticals Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2008
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2007
Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2007
Clarus Therapeutics Announces Completion of $8 Million Series C Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Oct 2007
Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two Businesses and Explore Strategic Alternatives with Respect to Its Generics Business
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Sep 2007
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III Study
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2007
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Biopharmaceuticals
 HSMN NewsFeed - 24 Jul 2007
The Journal of Hand Surgery Publishes Initial Phase III Data on XIAFLEX(TM) (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Jun 2007
BioSante Pharmaceuticals Announces the Commercial Launch of Elestrin(TM)
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2007
Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Feb 2007
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 2 Jan 2007
Antares ATD(TM) Formulation Enters Phase III Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Dec 2006
BioSante Pharmaceuticals Initiates Phase III Study of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 18 Dec 2006
BioSante Pharmaceuticals Receives FDA Approval of Bio-E-Gel(R) (estradiol gel), to be Marketed as Elestrin(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Dec 2006
Paladin and Auxilium Sign Exclusive Distribution Agreement for Testim'R'
Biopharmaceuticals Distribution
 HSMN NewsFeed - 12 Dec 2006
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Nov 2006
Cellegy Announces Stockholder Approval of Asset Sale to ProStrakan
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Nov 2006
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 18 Oct 2006
Auxilium Pharmaceuticals Announces R&D Portfolio Change
Biopharmaceuticals
 HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 13 Sep 2006
Unimed Pharmaceuticals, Inc. Settles AndroGel(R) Litigation with Watson Pharmaceuticals, Inc. and Paddock Laboratories/Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 13 Sep 2006
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 29 Jun 2006
Auxilium Pharmaceuticals Announces Start of U.S. Phase III Pivotal Trial of Testosterone Transmucosal Film (AA2600) for Hypogonadism
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2006
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of Acute Bacterial Sinusitis with FACTIVE Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jun 2006
Auxilium Appoints Armando Anido as Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2006
Auxilium Pharmaceuticals Receives Approval to Sell Testim(R) in Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2006
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 85

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 85 additional stories matching:
testosterone gel
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.